JeanPaul MD - Inventiva Head Pharmacovigilance
| IVA Stock | EUR 2.42 0.02 0.82% |
Insider
JeanPaul MD is Head Pharmacovigilance of Inventiva SA
| Phone | (33) 3 80 44 75 00 |
| Web | www.inventivapharma.com |
Inventiva Management Efficiency
The company has return on total asset (ROA) of (0.3438) % which means that it has lost $0.3438 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7073) %, meaning that it generated substantial loss on money invested by shareholders. Inventiva's management efficiency ratios could be used to measure how well Inventiva manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| David MD | Argen X | 71 | |
| Scott Jeffers | Gensight Biologics SA | N/A | |
| Pascal Wotling | DBV Technologies SA | N/A | |
| Prof Cepko | Gensight Biologics SA | N/A | |
| Karl Gubitz | Argen X | 53 | |
| Anne Pascard | Abivax SA | N/A | |
| Pr Ir | Argen X | 63 | |
| Andria Wilk | Argen X | 49 | |
| Dr MBA | Cellectis | 46 | |
| Raquel Lizarraga | Abivax SA | N/A | |
| Regina Jehle | Abivax SA | N/A | |
| Sbastien Robitaille | DBV Technologies SA | 53 | |
| Pr Roska | Gensight Biologics SA | N/A | |
| Adam Slatter | DBV Technologies SA | 51 | |
| Joseph Becker | DBV Technologies SA | N/A | |
| EMBA MBA | Argen X | 50 | |
| Valerie Cros | Cellectis | N/A | |
| Keith Woods | Argen X | 55 | |
| MSc MSc | Cellectis | 54 | |
| Kevin Trapp | DBV Technologies SA | 52 | |
| Paul Gineste | Abivax SA | N/A | |
Management Performance
| Return On Equity | -0.71 | |||
| Return On Asset | -0.34 |
Inventiva SA Leadership Team
Elected by the shareholders, the Inventiva's board of directors comprises two types of representatives: Inventiva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inventiva. The board's role is to monitor Inventiva's management team and ensure that shareholders' interests are well served. Inventiva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inventiva's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jean Volatier, Chief Officer | ||
| Eric LLM, G Counsel | ||
| Frederic Cren, CEO CoFounder | ||
| JeanPaul MD, Head Pharmacovigilance | ||
| Michael Cooreman, Chief Officer | ||
| Pierre Broqua, Chief CoFounder | ||
| Irena Konstantinova, Head Pharmacology | ||
| Nathalie Harroy, Head HR |
Inventiva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inventiva a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (6.37) % | |||
| Current Valuation | 103.5 M | |||
| Shares Outstanding | 42.13 M | |||
| Shares Owned By Insiders | 25.11 % | |||
| Shares Owned By Institutions | 47.27 % | |||
| Price To Book | 2.47 X | |||
| Price To Sales | 17.66 X | |||
| Revenue | 4.19 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Inventiva Stock
When determining whether Inventiva SA offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inventiva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inventiva Sa Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inventiva Sa Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inventiva SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.